Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)

BACKGROUND: This study evaluated the efficacy and safety of add-on gemigliptin in patients with type 2 diabetes mellitus (T2DM) who had inadequate glycemic control with metformin and dapagliflozin. METHODS: In this randomized, placebo-controlled, parallel-group, double-blind, phase III study, 315 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Byung Wan, Min, KyungWan, Hong, Eun-Gyoung, Ku, Bon Jeong, Kang, Jun Goo, Chon, Suk, Lee, Won-Young, Park, Mi Kyoung, Kim, Jae Hyeon, Kim, Sang Yong, Song, Keeho, Yoo, Soon Jib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323160/
https://www.ncbi.nlm.nih.gov/pubmed/37408283
http://dx.doi.org/10.3803/EnM.2023.1688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323160/
https://www.ncbi.nlm.nih.gov/pubmed/37408283
http://dx.doi.org/10.3803/EnM.2023.1688

Ejemplares similares